Gastric Cancer (FGFR2) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Gastric Cancer (FGFR2)
Gastric cancer, or stomach cancer, can be particularly challenging, especially when it involves specific genetic alterations like FGFR2. This subtype often requires specialized, and sometimes costly, treatments. TheDrugClub is dedicated to easing the financial burden for patients and families facing such diagnoses, helping you afford the vital medications needed for your care.
Gastric cancer is a serious condition where abnormal cells grow uncontrollably in the stomach lining. While there are various types, a particularly aggressive form is characterized by alterations in the Fibroblast Growth Factor Receptor 2 (FGFR2) gene. This genetic change can drive tumor growth and progression, making it a critical target for therapy. Identifying FGFR2 alterations through molecular testing is essential for guiding treatment decisions, as it signifies a specific pathway that can be targeted.
Traditional treatments for gastric cancer include surgery, chemotherapy, and radiation therapy. However, for patients with FGFR2-positive gastric cancer, targeted therapies offer a more precise approach. Medications like infigratinib (Truseltiq) and futibatinib (Lytgobi) are examples of FGFR inhibitors designed to block the activity of the altered FGFR2 gene, thereby slowing or stopping cancer growth. These advanced therapies, while offering significant hope, can often come with a substantial price tag. Other supportive medications to manage side effects are also frequently prescribed.
Managing the cost of these
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.